Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of the Effects of a Probiotic Formulation in Hemodialysis Patients
Brief Summary: Previous studies found that lactic acid bacteria could inhibit the activity of the performance of aristolochic acids (AAs) and improve apoptosis of proximal tubular epithelial cells (NRK-52E) and renal fibrosis on rats. The aim of this study is to assessment a novel health food of lactic acid bacteria for preventing renal dysfunction and replacing or assisting conventional drug treatment. This study in 300 hemodialysis patients with dialysis quality assessment index (KT/V, urea reduction ratio (URR), albumin, prealbumin, Hb, CRP...) screened for more than three months, and the stability of the situation in dialysis patients. They will be divided into two groups in order to conduct ergonomic assessments. One group maintains their original diet and medicine. The other group will take the novel lactic acid bacteria and placebo (1x1011 cfu/3±0.2 g/bag) in every morning and evening after their meals. The effect of 0, 6, 12, 18, 24 weeks of the novel lactic acid bacteria will be assessed after starvation for 4 weeks. Group C was the control group did not give any test samples, but continued to observe. The overall goal of the aforementioned study is to develop a novel food product of lactic acid bacteria which can improve dialysis quality for hemodialysis patients. The investigators hope that this novel product can get a patent and be commercialized.


Options:
A: Arm Label: probiotic soy milk; Type: EXPERIMENTAL; Interventions: Dietary Supplement: probiotic soy milk | Arm Label: soy milk; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: probiotic soy milk | Intervention Type: DIETARY_SUPPLEMENT; Name: probiotic soy milk; Assigned to Arm(s): probiotic soy milk, soy milk
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Arm Label: Probiotic packet; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Probiotic packet | Intervention Type: DIETARY_SUPPLEMENT; Name: Probiotic packet; Assigned to Arm(s): Probiotic packet | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Arm Label: Resistant Starch; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Resistant starch | Arm Label: Exercise & Resistant Starch; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Resistant starch, Behavioral: Exercise | Arm Label: Starch; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Starch | Intervention Type: DIETARY_SUPPLEMENT; Name: Resistant starch; Assigned to Arm(s): Exercise & Resistant Starch, Resistant Starch | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise, Exercise & Resistant Starch | Intervention Type: BEHAVIORAL; Name: Starch; Assigned to Arm(s): Starch
D: Arm Label: SYNBIOTIC; Type: EXPERIMENTAL; Interventions: Dietary Supplement: SYNBIOTIC | Arm Label: PLACEBO; Type: PLACEBO_COMPARATOR; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: SYNBIOTIC; Assigned to Arm(s): SYNBIOTIC

Answer: B